MARKET

RVPH

RVPH

Reviva Pharmaceutcls Hldgs Inc
OTCMQB
0.390
+0.038
+10.76%
Closed 15:59 05/14 EDT
OPEN
0.360
PREV CLOSE
0.352
HIGH
0.390
LOW
0.305
VOLUME
373.69K
TURNOVER
125.81K
52 WEEK HIGH
23.20
52 WEEK LOW
0.262
MARKET CAP
5.00M
P/E (TTM)
-0.0712
1D
5D
1M
3M
1Y
5Y
1D
Reviva Pharmaceuticals reports Q1 EPS (46c), consensus (29c)
TipRanks · 1d ago
Reviva Pharmaceuticals GAAP EPS of -$0.46 misses by $0.11
Seeking Alpha · 1d ago
*Reviva Pharm Holdings 1Q Loss/Shr 46c >RVPH
Dow Jones · 1d ago
Reviva Pharmaceuticals Q1 net loss narrows on lower expenses
Reuters · 1d ago
Reviva Pharmaceuticals Q1 EPS $(0.46) Beats $(0.62) Estimate
Benzinga · 1d ago
Press Release: Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights
Dow Jones · 1d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Chipmakers, Dynatrace, Alibaba
Reuters · 1d ago
More
About RVPH
Reviva Pharmaceuticals Holdings, Inc. is a late-stage pharmaceutical company. The Company discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system, inflammatory, and cardiometabolic diseases. Its pipeline includes two drug candidates, brilaroxazine (RP5063) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), behavioral and psychotic symptoms of dementia or Alzheimer’s disease (BPSD), and Parkinson’s disease psychosis. Brilaroxazine is also ready for clinical development for two respiratory indications, including pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). Its RP1208 drug candidate is a triple reuptake inhibitor (TRI).

Webull offers Reviva Pharmaceuticals Holdings Inc stock information, including OTCMQB: RVPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVPH stock methods without spending real money on the virtual paper trading platform.